Community

Advertising Opportunities

 Biotechnology Europe Programs

 Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

 

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe

Terms of Business

Imprint

Privacy Policy

FAQ

Subscribe Newsletter

 

Helmholtz Zentrum München News

   

 

 

   
     

   
 
   
   
   
 
   
   
   
   
   
   
   
   
   
   
   
   
   

post your news I subscribe newsletter I contact us

 
 
   

 

 

Important Clue to Understanding the Pathogenesis of Ciliary Disorders

26 July 2010 Neuherberg, Germany

 

A research team led by Dr. Heiko Lickert of Helmholtz Zentrum München has pinpointed a gene that is essential for the physiologically correct disassembly of cilia. Errors in the regulation of cilia assembly are implicated in a variety of human syndromes. Until now, however, the consequences of faulty cilia disassembly have not yet been elucidated. The findings are reported in the current issue of the prestigious journal Developmental Cell.

 

Scientists led by Dr. Heiko Lickert, research group leader at the Institute of Stem Cell Research of Helmholtz Zentrum München, have identified the first gene shown to regulate cilia disassembly in a living organism. If the gene is defective, double and forked cilia develop – thus the name Pitchfork. The consequences of the mutation include typical defects in the left-right asymmetry of body organs and heart failure.

 
 

The functional investigations were conducted primarily on the mouse model, together with the Institute of Developmental Genetics and the Department of Protein Analytics of Helmholtz Zentrum München. However, Dr. Lickert and his collaboration partner Nicolas Katsanis of Duke University in the U.S. were also able to show mutations in the Pitchfork gene in patients with ciliary diseases. In humans, the substitution of merely one amino acid in the Pitchfork protein can lead to an inversed position of all internal organs (situs inversus), to kidney and liver diseases, but also to severe heart defects. “Our study” Dr. Lickert said, “provides a new entry point to understand and categorize ciliary disease.”

  Prostate Cancer Translational Research in Europe: the search for biomarkers continues

Cryosurgery: Primary treatment option for prostate cancer
 

 

Background:

Cilia are hair-like cell protuberances, 5 to 10 µm long and 250 nm thick, which are present in almost all human or animal cells. They function like antennas in the cells and play a pivotal role in the perception of the cellular surroundings and signal transduction.

 

Defective cilia usually have genetic causes and severe consequences: In recent years more than 30 diseases could be traced to ciliary dysfunctions. These ciliopathies affect numerous organ systems and show diverse clinical symptoms, but the molecular and cellular basis for this is not yet understood. The resulting disorders include developmental defects such as polycystic kidney, liver and pancreas diseases (incidence 1:800) and also heart defects and adiposity. An increased risk for common diseases such as diabetes or cancer is also very probable. Despite the far-reaching significance of cilia, many aspects of the biology of these organelles are not yet known and many questions remain to be answered. These include the regulation of the body’s own processes (homeostasis), signal transduction between cells, organ and embryonic development, and the assembly and disassembly of cilia in the different phases of the cell cycle.

 

Further Information:

Original Publication: Kinzel D. et al.: Pitchfork regulates primary cilia disassembly and left-right asymmetry. Developmental Cell 2010; Developmental Cell 19(1) pp. 66 - 77 (pdf download).

 
 

Helmholtz Zentrum München is the German Research Center for Environmental Health. Our aim is to develop an individualized medical approach to the prevention and treatment of widespread common diseases such as diabetes mellitus, lung diseases and diseases of the nervous system. As one of the world’s leading centers with a focus on Environmental Health, we investigate the interaction of genetic disposition, environmental factors and lifestyle. Helmholtz Zentrum München has approximately 1800 staff members; its head office is located in Neuherberg to the north of Munich on a 50-hectare research campus. Helmholtz Zentrum München belongs to the Helmholtz Association, Germany’s largest research organization, a community of 16 scientific-technical and medical-biological research centers with a total of 26,500 staff members. – www.helmholtz-muenchen.de

 

The Institute of Stem Cell Research investigates the main regulatory elements of cell fate and cell proliferation in different organ systems. The scientists study stem cells of different organs, for instance of the nervous system or the hematapoietic system, to elucidate the molecular and cellular mechanisms responsible for the key characteristic common to all stem cells. Another main focus is the regulation of the generation of specific cell types from stem cells with respect to a reconstituting therapeutic approach - www.helmholtz-muenchen.de/isf

 

Contact for Media Representatives

Sven Winkler, Helmholtz Zentrum München – German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany - Phone: +49(0)89-3187-3946, Fax +49(0)89-3187-3324, Internet: www.helmholtz-muenchen.de, e-mail: presse@helmholtz-muenchen.de.

 

 

 

 

 

 

 

Stem Cells Market And Technologies
2009-2015


RNAi


Biomarkers


Nanobiotechnology


Gene Therapy


DNA sequencing


Stem Cell Markets

 

  More News I add this page to your favorites
Tinnitus – low heritability
The relative importance of genetic factors in tinnitus is low, according to new research from the Norwegian Institute of Public Health. This is the first large population-based study to measure the heritability of tinnitus. The study looked at prevalence of tinnitus and to what degree it is hereditary. Prevalence of tinnitus was 15.1 percent, which correlates well with findings from other countries.

 
Young men with HIV infection have coronary atherosclerotic plaques, MGH study
A Massachusetts General Hospital (MGH) study has found that relatively young men with longstanding HIV infection and minimal cardiac risk factors had significantly more coronary atherosclerotic plaques - some involving serious arterial blockage - than did uninfected men with similar cardiovascular risk. The investigation appearing in the January 2010 issue of the journal AIDS is the first to use CT angiography to identify coronary artery plaques in HIV-infected participants. "We were particularly surprised to find that several of the HIV patients - none of whom had symptoms of heart disease - had obstructive coronary artery disease, which was found in none of the controls," says Janet Lo, MD, of the Program in Nutritional Metabolism in the MGH Department of Medicine, who led the study. "It appears that both traditional and nontraditional risk factors are contributing to atherosclerotic disease in HIV-infected patients."

 

 
Findings linked to a key molecule active in GI inflammation
In the largest, most comprehensive genetic analysis of childhood-onset inflammatory bowel disease (IBD), an international research team has identified five new gene regions, including one involved in a biological pathway that helps drive the painful inflammation of the digestive tract that characterizes the disease. A research team led by Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at The Children's Hospital of Philadelphia, says that the findings advance the scientific understanding of how IBD develops. "This is an evolving story of discovering what genes tell us about the disease," said Robert N. Baldassano, M.D., a co-first author of the study and director of the Center for Pediatric Inflammatory Bowel Disease at Children's Hospital. "Pinpointing how specific genes act on biological pathways provides a basis for ultimately personalizing medicine to an individual's genetic profile."

 

 
Strong alkaline substances can damage teeth
It has long been known that acids can erode tooth enamel but a new Swedish study from the Sahlgrenska Academy at the University of Gothenburg, Sweden, shows that strong alkaline substances can damage teeth too - substances with high pH values can destroy parts of the organic content of the tooth, leaving the enamel more vulnerable. The study was carried out at the Department of Occupational and Environmental Medicine at the Sahlgrenska Academy and published in the Journal of Dentistry.

   

 

Phytochemicals in plant-based foods could help battle obesity, disease

The cheeseburger and French fries might look tempting, but eating a serving of broccoli or leafy greens first could help people battle metabolic processes that lead to obesity and heart disease, a new University of Florida study shows. Eating more plant-based foods, which are rich in substances...

   

 

A Novel Gene-Silencing Protein Offers New Possibilities for Treatment of Cancer and Genetic Disorders

A study published recently in the Proceedings of the National Academy of Science (PNAS) by a team of scientists headed by Professors Hélène Bierne and Pascale Cossart from the Pasteur Institute, in collaboration with colleagues form the CNRS and the French Agricultural Research Institute (INRA), identified a novel protein, BAHD1, which is responsible for changing DNA structure and silencing the expression of genes.

   
 
   
   
 I back I top I  
 

 
 
   

 

 

                                                                

office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com

 


 

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

About Biotechnology Europe

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe


 

Biotechnology Europe Your Partner in Bioscience and Business

  Central Internet Platform and Service Company For The Life Sciences in Europe

Imprint I Site map I Privacy Policy I Contact us I About us I Copyright BIOTECHNOLOGY WORLD  All rights reserved